#NextCell Pharma

Cellaviva Sverige April 27, 2021

Pediatric diabetes study with stem cells approved

Uppsala University Hospital and the principal investigator, Professor Per-Ola Carlsson, have been granted approval from the Medical Products Agency and the Swedish Ethical Review Authority to conduct a clinical drug trial with ProTrans™ to treat children and adolescents with type-1 diabetes. The study is a phase I / II study with a total of 66 patients.

Cellaviva Sverige February 2, 2021
Canadian Trial for ProTrans in COVID-19

Canadian Trial for ProTrans in COVID-19

TUE, FEB 02, 2021 15:50 CET NextCell Pharma AB (“NextCell”) today announces that Health Canada and the McGill University Health Centre Research Ethics Board have authorized the clinical trial entitled...